N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide

C94H95Cl4N31O5 — CID 158076119

IUPACN-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide
SMILESCN1CCN(CC(=O)Nc2nc(-c3cc(Cl)c4ncccc4c3)c(-c3ccn(C)n3)nc2N)C1.Cn1ccc(-c2nc(N)c(NC(=O)CC3CCCC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(N)c(NC(=O)CC3CCCCC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(N)c(NC(=O)CN3CC(O)C3)nc2-c2cc(Cl)c3ncccc3c2)n1
InChIInChI=1S/C25H26ClN7O.C24H24ClN7O.C23H24ClN9O.C22H21ClN8O2/c1-33-11-9-19(32-33)23-22(17-13-16-8-5-10-28-21(16)18(26)14-17)31-25(24(27)30-23)29-20(34)12-15-6-3-2-4-7-15;1-32-10-8-18(31-32)22-21(16-12-15-7-4-9-27-20(15)17(25)13-16)30-24(23(26)29-22)28-19(33)11-14-5-2-3-6-14;1-31-8-9-33(13-31)12-18(34)27-23-22(25)28-21(17-5-7-32(2)30-17)20(29-23)15-10-14-4-3-6-26-19(14)16(24)11-15;1-30-6-4-16(29-30)20-19(13-7-12-3-2-5-25-18(12)15(23)8-13)28-22(21(24)27-20)26-17(33)11-31-9-14(32)10-31/h5,8-11,13-15H,2-4,6-7,12H2,1H3,(H2,27,30)(H,29,31,34);4,7-10,12-14H,2-3,5-6,11H2,1H3,(H2,26,29)(H,28,30,33);3-7,10-11H,8-9,12-13H2,1-2H3,(H2,25,28)(H,27,29,34);2-8,14,32H,9-11H2,1H3,(H2,24,27)(H,26,28,33)
InChIKeyFMJVQXUZBRIQKL-UHFFFAOYSA-N
MW1880.82 g/mol
LogP14.50
Rot. Bonds20

About N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide

N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide (PubChem CID 158076119) has the molecular formula C94H95Cl4N31O5 and a molecular weight of 1880.82 g/mol. Its IUPAC name is N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide.

Molecular Properties

Compound NameN-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide
PubChem CID158076119
Molecular FormulaC94H95Cl4N31O5
Molecular Weight1880.82 g/mol
Exact Mass1877.69
IUPAC NameN-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide
SMILESCN1CCN(CC(=O)Nc2nc(-c3cc(Cl)c4ncccc4c3)c(-c3ccn(C)n3)nc2N)C1.Cn1ccc(-c2nc(N)c(NC(=O)CC3CCCC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(N)c(NC(=O)CC3CCCCC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(N)c(NC(=O)CN3CC(O)C3)nc2-c2cc(Cl)c3ncccc3c2)n1
InChIInChI=1S/C25H26ClN7O.C24H24ClN7O.C23H24ClN9O.C22H21ClN8O2/c1-33-11-9-19(32-33)23-22(17-13-16-8-5-10-28-21(16)18(26)14-17)31-25(24(27)30-23)29-20(34)12-15-6-3-2-4-7-15;1-32-10-8-18(31-32)22-21(16-12-15-7-4-9-27-20(15)17(25)13-16)30-24(23(26)29-22)28-19(33)11-14-5-2-3-6-14;1-31-8-9-33(13-31)12-18(34)27-23-22(25)28-21(17-5-7-32(2)30-17)20(29-23)15-10-14-4-3-6-26-19(14)16(24)11-15;1-30-6-4-16(29-30)20-19(13-7-12-3-2-5-25-18(12)15(23)8-13)28-22(21(24)27-20)26-17(33)11-31-9-14(32)10-31/h5,8-11,13-15H,2-4,6-7,12H2,1H3,(H2,27,30)(H,29,31,34);4,7-10,12-14H,2-3,5-6,11H2,1H3,(H2,26,29)(H,28,30,33);3-7,10-11H,8-9,12-13H2,1-2H3,(H2,25,28)(H,27,29,34);2-8,14,32H,9-11H2,1H3,(H2,24,27)(H,26,28,33)
InChIKeyFMJVQXUZBRIQKL-UHFFFAOYSA-N
XLogP14.50
TPSA476.39 Ų
H-Bond Donors9
H-Bond Acceptors32
Rotatable Bonds20
Heavy Atoms134
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001880.82
LogP ≤ 514.50
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1032

Analyze N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide?
The IUPAC name of N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide (CID 158076119) is N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide.
What is the SMILES notation for N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide?
The canonical SMILES for N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide is CN1CCN(CC(=O)Nc2nc(-c3cc(Cl)c4ncccc4c3)c(-c3ccn(C)n3)nc2N)C1.Cn1ccc(-c2nc(N)c(NC(=O)CC3CCCC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(N)c(NC(=O)CC3CCCCC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cn1ccc(-c2nc(N)c(NC(=O)CN3CC(O)C3)nc2-c2cc(Cl)c3ncccc3c2)n1.
What is the InChIKey of N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide?
The InChIKey is FMJVQXUZBRIQKL-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26ClN7O.C24H24ClN7O.C23H24ClN9O.C22H21ClN8O2/c1-33-11-9-19(32-33)23-22(17-13-16-8-5-10-28-21(16)18(26)14-17)31-25(24(27)30-23)29-20(34)12-15-6-3-2-4-7-15;1-32-10-8-18(31-32)22-21(16-12-15-7-4-9-27-20(15)17(25)13-16)30-24(23(26)29-22)28-19(33)11-14-5-2-3-6-14;1-31-8-9-33(13-31)12-18(34)27-23-22(25)28-21(17-5-7-32(2)30-17)20(29-23)15-10-14-4-3-6-26-19(14)16(24)11-15;1-30-6-4-16(29-30)20-19(13-7-12-3-2-5-25-18(12)15(23)8-13)28-22(21(24)27-20)26-17(33)11-31-9-14(32)10-31/h5,8-11,13-15H,2-4,6-7,12H2,1H3,(H2,27,30)(H,29,31,34);4,7-10,12-14H,2-3,5-6,11H2,1H3,(H2,26,29)(H,28,30,33);3-7,10-11H,8-9,12-13H2,1-2H3,(H2,25,28)(H,27,29,34);2-8,14,32H,9-11H2,1H3,(H2,24,27)(H,26,28,33).
What are the key properties of N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide?
N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide has a molecular weight of 1880.82 g/mol, XLogP of 14.50, 20 rotatable bonds, 9 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclohexylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylacetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-hydroxyazetidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)acetamide is sourced from PubChem (CID 158076119), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).